|
Market Closed -
Bombay S.E.
11:02:26 22/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 488.15 INR | -2.79% |
|
-6.14% | +10.60% |
| Market Cap | 35.35B 375M 334M 309M 280M 527M 533M 3.71B 1.45B 18.58B 1.41B 1.38B 59.22B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 37.46B 397M 354M 328M 296M 558M 565M 3.93B 1.54B 19.69B 1.49B 1.46B 62.75B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.74% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| UNICHEMLAB | Delayed | |
NSE India S.E.
| UNICHEMLAB | Delayed |
| 1 day | -2.79% | ||
| 1 week | -6.14% | ||
| Current month | -10.65% | ||
| 1 month | -8.70% | ||
| 3 months | -7.51% | ||
| 6 months | +31.90% | ||
| Current year | +10.60% |
| 1 week | 475 |  | 521.65 |
| 1 month | 475 | | 604 |
| Current year | 280 | | 685.95 |
| 1 year | 280 | | 685.95 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 07/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 21/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 09/08/2023 |
| Director/Board Member | 57 | 09/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.79% | -6.14% | +4.74% | +15.44% | 375M | |
| -1.01% | +5.13% | +58.93% | +117.36% | 1,133B | |
| -0.61% | +1.52% | +34.34% | +68.48% | 621B | |
| -1.48% | +0.47% | +23.08% | +94.76% | 503B | |
| -0.59% | +2.71% | +39.04% | +64.18% | 379B | |
| +1.07% | +1.70% | +71.06% | +45.98% | 370B | |
| +0.73% | +1.60% | +21.99% | +51.38% | 292B | |
| +0.69% | -0.08% | +1.18% | +25.62% | 262B | |
| -0.14% | +2.87% | +45.56% | +57.22% | 237B | |
| -1.88% | +0.02% | +23.77% | +97.39% | 190B | |
| Average | -0.18% | +2.55% | +32.37% | +63.78% | 398.84B | |
| Weighted average by Cap. | +0.37% | +3.73% | +40.83% | +79.82% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 224M 199M 185M 167M 315M 318M 2.21B 868M 11.1B 839M 822M 35.36B | 22.02B 233M 208M 192M 174M 328M 332M 2.31B 906M 11.57B 875M 857M 36.88B |
| Net income | 1.38B 14.57M 12.99M 12.02M 10.88M 20.5M 20.74M 144M 56.56M 723M 54.67M 53.53M 2.3B | 2.53B 26.79M 23.88M 22.1M 20M 37.69M 38.14M 265M 104M 1.33B 101M 98.42M 4.23B |
| Net Debt | 3.7B 39.23M 34.96M 32.36M 29.29M 55.18M 55.83M 388M 152M 1.95B 147M 144M 6.2B | 2.11B 22.32M 19.89M 18.42M 16.67M 31.4M 31.77M 221M 86.65M 1.11B 83.75M 82M 3.53B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/10/26 | ₹488.15 | -2.79% | 2,523 |
| 21/10/26 | ₹502.15 | -0.24% | 9,703 |
| 19/10/26 | ₹503.35 | -1.37% | 1,805 |
| 16/10/26 | ₹510.35 | -1.87% | 2,224 |
| 15/10/26 | ₹520.10 | +0.06% | 2,706 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
